Bioventus BVS Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's equity method investments?
- Bioventus (BVS) reported equity method investments of $2.1M in Q1 2026.
- How has Bioventus's equity method investments changed year-over-year?
- Bioventus's equity method investments increased by 19.7% year-over-year, from $1.76M to $2.1M.
- What is the long-term trend for Bioventus's equity method investments?
- Over 5 years (2020 to 2025), Bioventus's equity method investments has grown at a -34.7% compound annual growth rate (CAGR), from $19.38M to $2.29M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.